Assessment of Telangiectasias Improvement and Quality of Life in Breast Cancer Patients Treated with Pulsed Dye Laser
This study aims to observe the improvement in quality of life in breast cancer survivors with radiation-induced telangiectasias, who are undergoing treatment with pulsed dye laser.
Behavioral Data
Collected from today forward - ProspectiveBreast Diseases+6
+ Cardiovascular Diseases
+ Neoplasms
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 1, 2013
Actual date on which the first participant was enrolled.This study focuses on breast cancer survivors who have telangiectasias, which are small dilated blood vessels, on their radiated breast skin. The goal is to understand how the appearance of these telangiectasias, when improved by pulsed dye laser treatment, impacts the overall well-being of the patients. The study is important as it aims to enhance our understanding of how patients feel about the long-term effects of radiation on their skin, potentially leading to improved care and quality of life for breast cancer survivors. Patients participating in this study will undergo a series of treatments with a pulsed dye laser. This laser targets red blood vessels and delivers heat, causing the telangiectasias to shrink and become less noticeable. It has been safely used to treat telangiectasias on the skin of patients who received radiation for breast cancer. Throughout the study, patients will be asked to complete a questionnaire about their feelings towards the telangiectasias, their radiated skin, and how it affects their daily lives. The questionnaire will be given at every visit. The improvement in the appearance of the patients' radiated skin will also be compared to their responses to the questionnaire. The primary outcome of the study is to evaluate the quality of life in breast cancer survivors with chronic radiation-induced telangiectasias who are undergoing pulsed dye laser treatment, using two pre-existing validated scales, the Skindex-16 and BREAST-Q.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.22 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Memorial Sloan Kettering Cancer Center
New York, United StatesOpen Memorial Sloan Kettering Cancer Center in Google Maps